Inhibition of progesterone secretion by a 3β-hydroxysteroid dehydrogenase inhibitor in pregnant goats

1987 ◽  
Vol 113 (3) ◽  
pp. 489-493 ◽  
Author(s):  
M. J. Taylor

ABSTRACT Epostane, an inhibitor of 3β-hydroxysteroid dehydrogenase, was administered to goats in late pregnancy in the presence or absence of concurrent treatment with prostaglandin synthetase inhibitors (indomethacin and diclofenac sodium) and the effect on steroidogenesis in the corpus luteum and adrenal cortex determined by measurement of peripheral concentrations of progesterone and cortisol respectively. Concentrations of both steroids were reduced to about 20% of pretreatment levels within 6 h of epostane administration. Cortisol concentrations subsequently increased about 24 h after epostane administration and returned to and exceeded pretreatment values, but progesterone concentrations remained suppressed until premature delivery, which occurred in all animals 44 ± 2 h (mean ± s.e.m.) after epostane administration. However, combined administration of epostane and prostaglandin synthetase inhibitor prevented the onset of labour in the majority of animals, but progesterone secretion in animals receiving this combined treatment did not differ from that in animals given epostane alone. It is concluded that progesterone withdrawal is an important component of the mechanisms which initiate parturition in the goat and that increased prostaglandin synthesis is essential for delivery in this species, but perhaps not for luteolysis. J. Endocr. (1987) 113, 489–493

1987 ◽  
Vol 113 (1) ◽  
pp. 97-101 ◽  
Author(s):  
M. J. Taylor

ABSTRACT An inhibitor of 3β-hydroxysteroid dehydrogenase (3β-HSD) activity was administered to sheep in late pregnancy. A rapid fall in plasma progesterone concentrations followed, associated with premature delivery by all animals 44±3 h (s.e.m.) after administration of inhibitor. A significant (about twofold) increase in plasma concentrations of oestradiol-17β was detected immediately before delivery. These results demonstrate, in contrast to previous reports, that 3β-HSD inhibitors have the capacity consistently to induce premature delivery associated with increased oestrogen release in sheep. J. Endocr. (1987) 113, 97–101


2013 ◽  
Vol 62 (2) ◽  
pp. 34-42
Author(s):  
Tatyana Valeryevna Semenova ◽  
Yuliya Pavlovna Milyutina ◽  
Aleksandr Vartanovich Arutyunyan ◽  
Olga Nikolayevna Arzhanova

Tobacco smoking is one of the pressing issues of public health. Russia ranks among the countries with a very high smoking rate. Smoking frequency among pregnant women in St. Petersburg is about 26.4%, among which 18.9% of the women smoke every day, and the rest 7.5% of them on the occasion. Complications from pregnancy (threatening miscarriage, premature delivery, anaemia) and from labour and delivery (labour abnormalities) in the smoking women occurs at almost twice the rate in those non-smoking, threatening miscarriage and anaemia notably having a more severe clinical picture and being more reluctant to the therapy. Smoking is one of the risk factors of hyperhomocysteinemia, which is in turn a marker of the folate metabolism impairment in the organism. It has been shown that homocysteine plasma level increases in the smoking pregnant women. Besides, a significant decrease in folate plasma level has been found in the same women. It is a folate deficiency that most of all raises homocysteine level in blood plasma. It has been proved that elevated homocysteine level has a direct toxic effect on the endothelium. Microthrombosis and microcirculation loss result in a series of obstetric complications. In late pregnancy, hyperhomocysteinemia causes chronic fetoplacental insufficiency and chronic intrauterine hypoxia. Therefore, many complications from pregnancy, such as gestosis and fetoplacental insufficiency, are associated with hyperhomocysteinemia, which is most probably caused by the smoking derived folate metabolism impairment. Supplementary folate and vitamin B complex therapy may possibly improve the pregnancy and delivery outcome in the pregnant women with high homocysteine plasma level. This, however, requires supportive clinical trials. Smoking cessation at birth spacing and prevention of hyperhomocysteinemia must be an essential condition for favourable prognosis for pregnancy.


1983 ◽  
Vol 98 (2) ◽  
pp. 283-NP ◽  
Author(s):  
A. P. F. Flint ◽  
R. D. Burton ◽  
R. B. Heap

Concentrations of progesterone in arterial and ovarian, uterine and jugular venous plasma were determined in four Barbary sheep at various stages of pregnancy. The results, together with ovarian histology, show that the corpus luteum regresses before term in Barbary sheep, as in most breeds of domestic ewes. Uterine synthesis of progesterone was demonstrated in late pregnancy in two animals in which uterine venous levels of progesterone were increased two- to fourfold above arterial concentrations. The placenta contained 3β-hydroxysteroid dehydrogenase. Barbary sheep (diploid chromosome number, 2N = 58) therefore resemble the domestic sheep (2N = 54) rather than the goat (2N = 60) from the point of view of the source of the progesterone required for maintenance of pregnancy.


1981 ◽  
Vol 51 (6) ◽  
pp. 1562-1567 ◽  
Author(s):  
J. A. Kitterman ◽  
G. C. Liggins ◽  
J. A. Clements ◽  
G. Campos ◽  
C. H. Lee ◽  
...  

To study their effects on tracheal fluid (TF) production and surfactant flux, we gave 12-h infusions of prostaglandin synthetase inhibitors (PGSI) on 16 occasions to 10 fetal lambs at gestational ages (GA) of 125--141 days. Results were similar with both sodium meclofenamate (13.9 +/- 3.4 mg.kg-1, 12 studies) and indomethacin (33.6 +/- 8.0 mg.kg-1, 4 studies). All studies were done at least 6 days after surgery and 4 days before spontaneous birth. During infusions of PGSI, there were no changes in fetal arterial blood pressure, pH, PaO2, PaCO2, TF production or its concentration of sodium, potassium, and chloride; calcium concentration in TF increased slightly. We expressed tracheal surfactant flux as micrograms.kg-1.h-1 of saturated phosphatidylcholine (SPC). If control SPC flux was less than 5 micrograms.kg-1.h-1 (10 studies at GA of 125--141 days), it did not change during infusion of PGSI; however, if control was greater than 5 micrograms.kg-1.h-1 (6 studies at GA 132--140 days), SPC flux decreased during the infusions in all studies. The results suggest that prostaglandins do not strongly influence TF production up to 4 days before birth and that prostaglandins are involved in the increased flux of surfactant which occurs in late gestation.


2018 ◽  
Vol 192 ◽  
pp. 251-260 ◽  
Author(s):  
Marta Różycka ◽  
Patrycja Kurowska ◽  
Małgorzata Grzesiak ◽  
Małgorzata Kotula-Balak ◽  
Wacław Tworzydło ◽  
...  

1983 ◽  
Vol 11 (5) ◽  
pp. 303-307 ◽  
Author(s):  
A Vignoni ◽  
A Fierro ◽  
G Moreschini ◽  
M Cau ◽  
A Agostino ◽  
...  

A randomized prospective double-blind study of the analgesic effect of 75 mg intramuscular diclofenac sodium (Voltaren®), a potent prostaglandin synthetase inhibitor, versus placebo (saline solution) was carried out in 131 consecutive patients with acute ureteral colic. Diclofenac provided complete relief of pain 25 minutes after the injection in 59% of the cases, while placebo provided relief in 29% (p < 0·01). Forty patients in the placebo group and seventeen patients in the diclofenac group needed an open injection of 75 mg diclofenac intramuscularly after 25 minutes due to persistent pain. Fifty-four of the fifty-seven patients treated with an open injection of diclofenac achieved complete relief of pain after 30 minutes. There were no side-effects of the treatment.


1998 ◽  
Vol 275 (6) ◽  
pp. E1037-E1045
Author(s):  
Francisco Tejada ◽  
Asunción Cremades ◽  
Manuel Avilés ◽  
Maria T. Castells ◽  
Rafael Peñafiel

Hypokalemia produced different effects on steroid sex hormone concentrations in plasma and ovary in the mouse. Estradiol levels were slightly increased, whereas circulating progesterone was markedly decreased in all estrous periods. The preovulatory surge of gonadotropins and the secondary surge of follicle-stimulating hormone (FSH) at estrus were also decreased, but basal levels of both gonadotropins were unaffected. Supplementation with luteinizing hormone (LH), FSH, or gonadotropin-releasing hormone (GnRH) at proestrus rapidly normalized plasma and ovarian progesterone levels at this stage of the estrous cycle. Plasma progesterone levels at diestrus were restored only by combined treatment, at the periovulatory stage, with LH and FSH or GnRH but not by LH or FSH alone. The results demonstrate a lack of steroidogenic activity in the corpus luteum of the potassium-deficient mice and, furthermore, that FSH plays an important role in luteinization in the hypokalemic mice. We conclude that alteration of the transcellular potassium gradient may affect the regulation of the periovulatory surge of gonadotropins and progesterone secretion, probably by altering the release of GnRH from the hypothalamus. In addition, the results suggest that FSH may play a certain role as a luteotropic hormone in mice.


1977 ◽  
Vol 52 (6) ◽  
pp. 615-620 ◽  
Author(s):  
N. A. Plummer ◽  
C. N. Hensby ◽  
A. Kobza Black ◽  
M. W. Greaves

1. Pharmacologically active mediators of inflammation were obtained from suction bullae raised on normal and inflamed human abdominal skin. These contained a clear inflammatory exudate, which was analysed for known mediators of inflammation. 2. The exudates were examined for smooth muscle-contracting activity by a superfusion cascade bioassay, for prostaglandin F2α by radioimmunoassay and by Lipidex 5000 gel-partition chromatography for other prostaglandins and related compounds. 3. Tetrahydrofurfuryl nicotinate (Trafuril) was applied topically before and after systemic administration of aspirin. Trafuril alone caused a sustained inflammatory response within minutes of application, which was reduced by prior administration of aspirin (a known prostaglandin synthetase inhibitor). 4. Exudate from inflamed skin showed increased prostaglandin activity compared with exudate from contralateral non-inflamed skin. However, aspirin prevented this increase in prostaglandin activity. Analysis by thin-layer and gas—liquid chromatography further suggested that Trafuril-induced inflammation was mediated by certain prostaglandins and related compounds. 5. No evidence was obtained to suggest any change in histamine or bradykinin after Trafuril. We suggest that the response caused by Trafuril is mediated by increased synthesis of prostaglandins. Aspirin, by blocking prostaglandin synthesis, prevents or reduces the erythema.


Sign in / Sign up

Export Citation Format

Share Document